Neuronetics, Inc. balance sheet

At the end of fiscal 2025, Neuronetics, Inc. had total assets of $142m, total liabilities of $115m and shareholders' equity of $22.4m. It held $28.1m in cash against $70.0m of debt: net debt of $41.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Neuronetics, Inc.: balance sheet, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	17	29	105	76	49	94	70	60	18	28	19
Receivables	—	4	6	7	7	8	14	16	23	16	16
Inventory	—	2	2	3	4	7	9	8	4	4	6
Total current assets	—	37	114	88	65	115	99	94	58	62	53
Goodwill	—	—	—	—	—	—	—	—	19	24	24
Total assets	—	39	117	100	79	141	117	116	141	142	132
Accounts payable	—	3	4	5	4	4	2	5	11	11	12
Deferred revenue (current)	—	2	2	2	2	3	2	2	1	1	1
Total current liabilities	—	12	14	28	14	16	33	20	31	31	28
Short-term debt	—	0	—	11	—	—	13	—	—	—	—
Long-term debt	—	30	30	20	35	35	23	59	55	66	62
Total debt	0	30	30	31	35	35	36	60	60	70	65
Total liabilities	—	44	46	52	53	56	60	82	109	115	110
Shareholders' equity	−177	−193	71	48	25	85	57	34	28	22	18
Non-controlling interests and other (assets − liabilities − equity)	—	187	—	—	—	—	—	—	4	4	4
Net debt (negative = net cash)	−17	1	−74	−45	−14	−59	−34	0	42	42	46
Shares outstanding	—	—	35m	37m	38m	53m	55m	58m	56m	69m	76m

US$ millions unless shown otherwise. Fiscal quarters.

Neuronetics, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	17	23	26	26	19	16	16	16
Inventory	5	4	4	5	4	4	5	6
Total current assets	53	58	61	56	65	62	47	53
Goodwill	—	19	19	19	23	24	24	24
Total assets	74	141	142	135	145	142	125	132
Accounts payable	3	11	8	10	12	11	11	12
Deferred revenue (current)	1	1	1	1	1	1	1	1
Total current liabilities	17	31	25	28	29	31	28	28
Long-term debt	46	55	55	56	66	66	61	62
Total debt	46	55	55	56	66	66	61	62
Total liabilities	65	109	102	103	114	115	108	110
Shareholders' equity	9	28	35	27	27	22	13	18
Non-controlling interests and other (assets − liabilities − equity)	—	4	4	4	4	4	4	4
Shares outstanding	30m	56m	66m	66m	68m	69m	70m	76m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: INFU vs STIM RXST vs STIM BBNX vs STIM LAKE vs STIM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuronetics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuronetics, Inc.